Hydralazine
Back to searchMolecule Structure
Scientific Name
Hydralazine
Description of the Drug
Hydralazine is an antihypertensive agent used for the management of essential hypertension or severe hypertension associated with conditions requiring immediate action, heart failure, and pre-eclampsia or eclampsia .
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01275
http://www.drugbank.ca/drugs/DB01275
Brand Name(s)
Not Available
Company Owner(s)
Alkem Laboratories Ltd, Vitarine Pharmaceuticals Inc, Sun Pharmaceutical Industries Inc, Halsey Drug Co Inc, Watson Laboratories Inc, Ascot Hosp Pharmaceuticals Inc Div Travenol Laboratories Inc, Invagen Pharmaceuticals Inc, American Regent Inc, Mylan Pharmaceuticals Inc, Purepac Pharmaceutical Co
Mechanism(s) Of Action
Not Available
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL7810 | |
| PharmGKB | PA449894 | |
| Human Metabolome Database | HMDB0015400 | |
| DrugBank | DB01275 | |
| PubChem: Thomson Pharma | 15171016 | |
| PubChem | 3637 | |
| Mcule | MCULE-9226495081 | |
| NMRShiftDB | 20202075 | |
| LINCS | LSM-15370 | |
| Nikkaji | J4.262E | |
| PDBe | HLZ | |
| BindingDB | 81461 | |
| EPA CompTox Dashboard | DTXSID4023129 | |
| DrugCentral | 1384 | |
| Brenda | 42831 | 2844 |
| ChemicalBook | CB1855362 | |
| Guide to Pharmacology | 7326 | |
| rxnorm | HYDRALAZINE HYDROCHLORIDE | HYDRALAZINE |
| KEGG Ligand | C07040 | |
| ChEBI | 5775 | |
| ZINC | ZINC000012360535 |
